Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
![Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias](https://www.degruyter.com/document/doi/10.1515/cclm-2015-0580/asset/graphic/j_cclm-2015-0580_fig_001.jpg)
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
![Combined immunoglobulin G kappa nephropathy: monoclonal immunoglobulin deposition disease and proximal tubulopathy: monoclonal gammopathy of renal significance or smoldering multiple myeloma? Case report and review of literature Combined immunoglobulin G kappa nephropathy: monoclonal immunoglobulin deposition disease and proximal tubulopathy: monoclonal gammopathy of renal significance or smoldering multiple myeloma? Case report and review of literature](https://www.oatext.com/img/ICST-4-225-g015.gif)
Combined immunoglobulin G kappa nephropathy: monoclonal immunoglobulin deposition disease and proximal tubulopathy: monoclonal gammopathy of renal significance or smoldering multiple myeloma? Case report and review of literature
![Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression - Kyle - 2007 - British Journal of Haematology - Wiley Online Library Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression - Kyle - 2007 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3f1a3046-cdc1-4b92-bcac-51ed154a3f89/bjh_6873_f1.gif)
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression - Kyle - 2007 - British Journal of Haematology - Wiley Online Library
Generation of Novel Anti-MUC1 Monoclonal Antibodies with Designed Carbohydrate Specificities Using MUC1 Glycopeptide Library | ACS Omega
![Frontiers | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells Frontiers | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells](https://www.frontiersin.org/files/Articles/620427/fimmu-12-620427-HTML/image_m/fimmu-12-620427-g001.jpg)
Frontiers | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells
![Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology](https://www.thelancet.com/cms/attachment/7a920242-050b-49bd-a25d-a1e4b38371ca/gr1_lrg.jpg)
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology
A propos de l'électrophorèse des protéines sériques, du pic monoclonal, des gammaglobulines et des IgM du dosage pondéra
![Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0592-z/MediaObjects/12929_2019_592_Fig2_HTML.png)
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text
![Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics | HTML Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics | HTML](https://www.mdpi.com/antibodies/antibodies-08-00055/article_deploy/html/images/antibodies-08-00055-g009.png)
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics | HTML
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
![Biclonal Gammopathy of Iga Kappa Variant in a Patient with Systemic Lupus Erythematosus: A Case Report Biclonal Gammopathy of Iga Kappa Variant in a Patient with Systemic Lupus Erythematosus: A Case Report](http://clinmedjournals.org/articles/cmrcr/cmrcr-8-353-001.jpg)
Biclonal Gammopathy of Iga Kappa Variant in a Patient with Systemic Lupus Erythematosus: A Case Report
![Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains](https://www.degruyter.com/document/doi/10.1515/cclm-2016-0364/asset/graphic/j_cclm-2016-0364_fig_002.jpg)
Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains
![Mon médecin m'a prescrit un dosage des anticorps/immunoglobulines, je souhaite comprendre les résultats. - Questions fréquentes - Une question en santé ? - Cité de la santé - Lieux ressources - Au Mon médecin m'a prescrit un dosage des anticorps/immunoglobulines, je souhaite comprendre les résultats. - Questions fréquentes - Une question en santé ? - Cité de la santé - Lieux ressources - Au](https://www.cite-sciences.fr/fileadmin/fileadmin_CSI/fichiers/au-programme/lieux-ressources/cite-de-la-sante/_images/Questions_sante/Electrophorese__proteines.png)
Mon médecin m'a prescrit un dosage des anticorps/immunoglobulines, je souhaite comprendre les résultats. - Questions fréquentes - Une question en santé ? - Cité de la santé - Lieux ressources - Au
![Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft | BMC Nephrology | Full Text Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-019-1239-8/MediaObjects/12882_2019_1239_Fig2_HTML.png)
Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft | BMC Nephrology | Full Text
![The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-018-0077-4/MediaObjects/41581_2018_77_Fig1_HTML.png)
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology
![Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients | Leukemia Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.197/MediaObjects/41375_2013_Article_BFleu2012197_Fig1_HTML.jpg)